1'-(2-Phenyl-ethylene)-ditryptophenaline, a new dimeric diketopiperazine from Aspergillus flavus

Area of Science:

• Natural Product Chemistry
• Mycology
• Pharmacology

Background:

• Fungi, particularly Aspergillus species, are prolific sources of diverse secondary metabolites.
• Diketopiperazines represent a significant class of fungal metabolites with a broad range of biological activities.
• Substance-P plays a crucial role in pain and inflammation pathways, making its antagonists potential therapeutic agents.

Purpose of the Study:

• To isolate and characterize novel diketopiperazine dimers from Aspergillus flavus.
• To investigate the substance-P inhibitory activity of the isolated compounds.
• To explore the structure-activity relationship concerning stereochemistry and biological potency.

Main Methods:

• Fungal cultivation and extraction.
• Chromatographic isolation techniques (e.g., HPLC).
• Spectroscopic analysis (NMR, Mass Spectrometry) for structural elucidation.
• In vitro assays to measure substance-P inhibition.

Main Results:

• Isolation and identification of a new diketopiperazine dimer, 1'-(2-phenyl-ethylene)-ditryptophenaline [1], and ditryptophenaline [2].
• Structural determination of compound [1] via comprehensive spectroscopic data analysis.
• Both compounds [1] and [2] exhibited weak inhibition of substance-P.
• Comparison with substance-P antagonist WIN 64821 [3] revealed differences in inhibitory potency.

Conclusions:

• Stereochemistry at the dimerization site is a critical factor influencing the biological potency of these diketopiperazine derivatives.
• The findings contribute to understanding the structure-activity relationships of fungal diketopiperazines as potential therapeutic leads.
• Further research may focus on synthesizing analogs with optimized stereochemistry for enhanced substance-P antagonism.